Clinical Trials Directory

Trials / Unknown

UnknownNCT06678802

SNORD3A IN ISCHEMIC HEART DISEASE AND HEART FAILURE

ROLE OF CIRCULATING SMALL NUCLEOLAR RNA SNORD3A IN ISCHEMIC HEART DISEASE AND HEART FAILURE

Status
Unknown
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective, non-randomized, single center, open label clinical study enrolling patients affected by 1) chronic ischemic heart disease with evidence or suspect significant myocardial ischemia (group 1, CCS) or 2) acute coronary syndromes (group 2, ACS), both undergoing coronary angiography and eventually coronary revascularization at the Department of Scienze Cardiovascolari, Diagnostica per Immagini ed Emergenze Cardiovascolari of Federico II University Hospital, Naples, Italy. Age and sex-matched healthy volunteers without known ischemic heart disease (group 3, Ctr) will also be included as a control group. At enrollment (time 0), and after 48 hours (time 48 h), 1 month (time 1mo) and 6 month-follow-up visits (time 6 mo), clinical evaluation, ECG, trans-thoracic echocardiography and blood sampling will be performed, to isolate peripheral blood mononuclear cells (PBMC) and perform standard blood tests. The enrolment phase will last 24 months, and will likely involve 450 patients distributed as follows, according to the number of patients annually referring to our University Hospital: 1. Group 1, n= 200 patients with chronic ischemic heart disease undergoing coronary angiography and eventually coronary revascularization; 2. Group 2, n= 200 patients with ACS undergoing coronary angiography and eventually coronary revascularization ; 3. Group 3, n= 50, healthy volunteers.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplingblood sampling from peripheral vein

Timeline

Start date
2024-03-01
Primary completion
2025-08-30
Completion
2026-02-28
First posted
2024-11-07
Last updated
2024-11-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06678802. Inclusion in this directory is not an endorsement.